MARKET
| Issue | Title | |
| Vol 2, No 1 (2022) | Real-world evidence market: key players and key segments | Abstract PDF (Rus) |
| A. R. Kasimova, A. S. Kolbin | ||
| 1 - 1 of 1 Items | ||
Section Details
Popular articles
Vol 1, No 1 (2021)
Vol 1, No 1 (2021)
Vol 1, No 1 (2021)
Vol 2, No 1 (2022)
Vol 1, No 1 (2021)
Keywords
COVID-19
Chinese experience
Eurasian Economic Union
R
RWD
RWE
Russia
clinical registries
drug interactions
drug safety
favipiravir
international experience
medicinal plant
medicinal plant materials
molnupiravir
observation programs
pharmacovigilance
real-world data
real-world evidence
regulatory approaches
umifenovir
